Abstract
Diabetic retinopathy and glaucoma are major diseases that cause blindness in a high percentage of the population. However, the precise mechanisms involved in the onset and the progression of these diseases are still not completely known. Recent studies have shown that there appears to be an association between these two disease processes because the incidence of glaucoma is higher in diabetic patients than in non-diabetic patients. To reduce the number of patients with vision loss from these diseases, new therapeutic strategies must be established to prevent the development and the progression of these diseases. In this report, we focus on the biochemical links between diabetic retinopathy and glaucoma, viz., an overexpression of extracellular matrix and death of retinal ganglion cells. To establish new therapeutic strategies for both diseases, the biochemical links between diabetic retinopathy and glaucoma and an identification of the factors that are common to the pathogenesis of both diseases, must be determined. In addition, the potential use of gene therapies including antisense oligonucleotides and small interference RNAs should be considered for both diseases. We expect that with the advent of new therapies, a larger number of patients with diabetic retinopathy and/or glaucoma will be cured.
Keywords: Diabetic retinopathy, glaucoma, extracellular matrix, retinal ganglion cell death, antisense oligonucleotides, small interference RNA
Current Drug Therapy
Title: Common Therapeutic Strategies for Diabetic Retinopathy and Glaucoma
Volume: 2 Issue: 3
Author(s): Toshiyuki Oshitari and Sayon Roy
Affiliation:
Keywords: Diabetic retinopathy, glaucoma, extracellular matrix, retinal ganglion cell death, antisense oligonucleotides, small interference RNA
Abstract: Diabetic retinopathy and glaucoma are major diseases that cause blindness in a high percentage of the population. However, the precise mechanisms involved in the onset and the progression of these diseases are still not completely known. Recent studies have shown that there appears to be an association between these two disease processes because the incidence of glaucoma is higher in diabetic patients than in non-diabetic patients. To reduce the number of patients with vision loss from these diseases, new therapeutic strategies must be established to prevent the development and the progression of these diseases. In this report, we focus on the biochemical links between diabetic retinopathy and glaucoma, viz., an overexpression of extracellular matrix and death of retinal ganglion cells. To establish new therapeutic strategies for both diseases, the biochemical links between diabetic retinopathy and glaucoma and an identification of the factors that are common to the pathogenesis of both diseases, must be determined. In addition, the potential use of gene therapies including antisense oligonucleotides and small interference RNAs should be considered for both diseases. We expect that with the advent of new therapies, a larger number of patients with diabetic retinopathy and/or glaucoma will be cured.
Export Options
About this article
Cite this article as:
Oshitari Toshiyuki and Roy Sayon, Common Therapeutic Strategies for Diabetic Retinopathy and Glaucoma, Current Drug Therapy 2007; 2 (3) . https://dx.doi.org/10.2174/157488507781695685
DOI https://dx.doi.org/10.2174/157488507781695685 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Adenosine Neuromodulation and Traumatic Brain Injury
Current Neuropharmacology The AKT Axis as a Therapeutic Target in Autoimmune Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Cannabinoid System in Neurodegeneration: New Perspectives in Alzheimers Disease
Mini-Reviews in Medicinal Chemistry Oxytocin as a Potential Adjuvant Against COVID-19 Infection
Endocrine, Metabolic & Immune Disorders - Drug Targets Endothelial Chemokines in Autoimmune Disease
Current Pharmaceutical Design Pathophysiogenesis of Mesial Temporal Lobe Epilepsy: Is Prevention of Damage Antiepileptogenic?
Current Medicinal Chemistry Small Molecule Antagonists of Integrin Receptors
Current Medicinal Chemistry Hyperglycemia-Related Pathophysiologic Mechanisms and Potential Beneficial Actions of Melatonin
Mini-Reviews in Medicinal Chemistry Nitric Oxide-Derived Oxidants with a Focus on Peroxynitrite: Molecular Targets,Cellular Responses and Therapeutic Implications
Current Pharmaceutical Design Melatonin in Pregnancy: Effects on Brain Development and CNS Programming Disorders
Current Pharmaceutical Design Overview of Medicinally Important Diterpenoids Derived from Plastids
Mini-Reviews in Medicinal Chemistry Epigenetic Evaluation of N-(2-hydroxyphenyl)-2-Propylpentanamide, a Valproic Acid Aryl Derivative with Activity Against HeLa Cells
Current Molecular Pharmacology Lipoic Acid: A Novel Therapeutic Approach for Multiple Sclerosis and Other Chronic Inflammatory Diseases of the CNS
Endocrine, Metabolic & Immune Disorders - Drug Targets Estrogen Regulation of MicroRNA Expression
Current Genomics Transcranial Doppler Ultrasonography: Current Status
Current Medical Imaging Editorial (Thematic Issue: Calcium in Heart Disease: The Ubiquitous Ion)
Medicinal Chemistry Inhibition of IκB Phosphorylation by a Novel IKK Inhibitor IMD-1041 Attenuates Myocardial Dysfunction After Infarction
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Proanthocyanidins in Health Care: Current and New Trends
Current Medicinal Chemistry Inflammatory and Vascular Alterations in Sepsis: The Role of Nitric Oxide- Dependent Mechanisms
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Anti-Thrombotic Properties of Tomato
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery